Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: Results from the China National Stroke Registry

Journal of Stroke and Cerebrovascular Diseases

Volumn 23, Issue 5, 2014, Pages 1157-1163

  Wang, Chunjuan ^a   Yang, Zhonghua ^a   Wang, Chunxue ^a   Wang, Yilong ^a   Zhao, Xingquan ^a   Liu, Liping ^a   Wang, David Z ^b   Li, Hao ^a   Wang, Yongjun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Anticoagulation; atrial fibrillation; stroke management; transient ischemic attack; warfarin

Indexed keywords

ANTITHROMBOCYTIC AGENT; WARFARIN; ANTICOAGULANT AGENT;

ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN ISCHEMIA; CHADS2 SCORE; CHINA; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC HEART DISEASE; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK REDUCTION; TRANSIENT ISCHEMIC ATTACK; ADOLESCENT; ATRIAL FIBRILLATION; CHI SQUARE DISTRIBUTION; CLINICAL PRACTICE; CORONARY DISEASE; EPIDEMIOLOGY; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRACTICE GUIDELINE; REGISTER; RISK; RISK FACTOR; STATISTICAL MODEL; STROKE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CHI-SQUARE DISTRIBUTION; CHINA; CORONARY DISEASE; FEMALE; GUIDELINE ADHERENCE; HUMANS; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC ATTACK, TRANSIENT; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; REGISTRIES; RISK FACTORS; STROKE; TREATMENT OUTCOME; WARFARIN; YOUNG ADULT;

EID: 84901377479     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2013.10.006     Document Type: Article

References (21)

1. P. Wolf, R. Abbott, and W. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
2. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation N Engl J Med 323 1990 1505 1511
3. M.D. Ezekowitz, S.L. Bridgers, and K.E. James et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation N Engl J Med 327 1992 1406 1412
4. I.M. Ogilvie, N. Newton, and S.A. Welner et al. Underuse of oral anticoagulants in atrial fibrillation: a systematic review Am J Med 123 2010 638 645.e634
5. C.J. Mercaldi, M. Ciarametaro, and B. Hahn et al. Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation Stroke 42 2011 112 118
6. Z.Q. Zhou, D.Y. Hu, and J. Chen et al. An epidemiological survey of atrial fibrillation in China Chin J Intern Med 43 2004 491 494
7. W.H. Qi Retrospective investigation of hospitalized patients with atrial fibrillation in major parts of China Chin J Cardiol 31 2003 913 915
8. Y. Wang, L. Cui, and X. Ji et al. The China National Stroke Registry for patients with acute cerebrovascular events: design, rationale, and baseline patient characteristics Int J Stroke 6 2011 355 361
9. S. Li, X. Zhao, and C. Wang et al. Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation J Stroke Cerebrovasc Dis 13 2013 146 148
10. B.F. Gage, A.D. Waterman, and W. Shannon et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
11. D.J. Gladstone, E. Bui, and J. Fang et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated Stroke 40 2009 235 240
12. L. Boulanger, J. Kim, and M. Friedman et al. Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practice Int J Clin Pract 60 2006 258 264
13. R. Nieuwlaat, A. Capucci, and G.Y. Lip et al. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation Eur Heart J 27 2006 3018 3026
14. S. Goto, D.L. Bhatt, and J. Rother et al. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis Am Heart J 156 2008 855 863 863.e2
15. S. Hopps, and T.R. Marcy Warfarin versus aspirin: using CHADS2 to guide therapy for stroke prevention in nonvalvular atrial fibrillation Consult Pharm 24 2009 841 844
16. B.H. Lee, J.S. Park, and J.H. Park et al. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1 J Cardiovasc Electrophysiol 21 2010 501 507
17. T.J. Bungard, W.A. Ghali, and K.K. Teo et al. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 160 2000 41 46
18. S.L. Partington, S. Abid, and K. Teo et al. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: the appropriate use and barriers to oral anticoagulant therapy Thromb Res 120 2007 663 669
19. M. Man-Son-Hing, and A. Laupacis Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded Arch Intern Med 163 2003 1580 1586
20. J. Mant, F.D. Hobbs, and K. Fletcher et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial Lancet 370 2007 493 503
21. R.C. Becker, T.W. Meade, and P.B. Berger et al. The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 776S 814S